The role of type IV collagen and basement membranes in cancer progression and metastasis

American Journal of Pathology

Volumn 168, Issue 3, 2006, Pages 715-717

  Tanjore, Harikrishna ^a   Kalluri, Raghu ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

AMINO TERMINAL SEQUENCE; BASEMENT MEMBRANE; CANCER; CANCER GROWTH; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; METASTASIS; NOTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 33644641087     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051321     Document Type: Note

References (19)

1. Kalluri R: Basement membranes: structure, assembly and role in tumor angiogenesis. Nat Rev Cancer 2003, 3:422-433
2. Ikeda K, Iyama K, Ishikawa N, Egami H, Nakao M, Sado Y, Ninomiya Y, Baba H: Loss of expression of type IV collagen α5 and α6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am J Pathol 2006, 168:856-865
3. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R: Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000, 275:1209-1215
4. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R: Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 2003, 3:589-601
5. Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R: Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002, 295:140-143
6. Sudhakar A, Nyberg P, Keshamouni VG, Mannam AP, Li J, Sugimoto H, Cosgrove D, Kalluri R: Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 2005, 115:2801-2810
7. Pasco S, Ramont L, Venteo L, Pluot M, Maquart FX, Monboisse JC: In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res 2004, 301:251-265
8. Dehan P, Waltregny D, Beschin A, Noel A, Castronovo V, Tryggvason K, De Leval J, Foidart JM: Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. Am J Pathol 1997, 51:1097-1104
9. Tanaka K, Iyama K, Kitaoka M, Ninomiya Y, Oohashi T, Sado Y, Ono T: Differential expression of alpha 1(IV), alpha 2(IV), alpha 5(IV) and alpha 6(IV) collagen chains in the basement membrane of basal cell carcinoma. Histochem J 1997, 29:563-570
10. Barsky SH, Siegel GP, Jannotta F, Liotta LA: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983, 49:140-147
11. Havenith MG, Arends JW, Simon R, Volovics A, Wiggers T, Bosman FT: Type IV collagen immunoreactivity in colorectal cancer: prognostic value of basement membrane deposition. Cancer 1988, 62:2207-2211
12. Aumailley M, Timpl R: Attachment of cells to basement membrane collagen type IV. J Cell Biol 1986, 103:1569-1575
13. Offerhaus GJ, Giardiello FM, Bruijn JA, Stijnen T, Molyvas EN, Fleuren GJ: The value of immunohistochemistry for collagen IV expression in colorectal carcinomas. Cancer 1991, 67:99-105
14. Timpl R, Wiedemann H, van Delden V, Furthmayr H, Kuhn K: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981, 120:203-211
15. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 1997, 99:2470-2478
16. Nakano S, Iyama K, Ogawa M, Yoshioka H, Sado Y, Oohashi T, Ninomiya Y: Differential tissular expression and localization of type IV collagen alpha1(IV), alpha2(IV), alpha3(IV), and alpha6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors. Lab Invest 1999, 79:281-292
17. Sund M, Maeshima Y, Kalluri R: Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alphas and alpha6 chains in a distinct cell-specific fashion. Biochem J 2005, 387:755-761
18. Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16:168-174
19. Sathyanarayana UG, Padar A, Suzuki M, Maruyama R, Shigematsu H, Hsieh JT, Frenkel EP, Gazdar AF: Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2003, 9:6395-6400